216 related articles for article (PubMed ID: 11302868)
1. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.
Pertovaara M; Pukkala E; Laippala P; Miettinen A; Pasternack A
Ann Rheum Dis; 2001 May; 60(5):467-72. PubMed ID: 11302868
[TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
3. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
[TBL] [Abstract][Full Text] [Related]
4. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
5. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
[TBL] [Abstract][Full Text] [Related]
7. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
8. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).
Kauppi M; Pukkala E; Isomäki H
Cancer Causes Control; 1997 Mar; 8(2):201-4. PubMed ID: 9134244
[TBL] [Abstract][Full Text] [Related]
9. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
Weng MY; Huang YT; Liu MF; Lu TH
Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
[TBL] [Abstract][Full Text] [Related]
10. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
11. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
ter Borg EJ; Kelder JC
Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren's syndrome.
Yan S; Li M; Wang H; Yang X; Zhao J; Wang Q; Liu Y; Lai J; Tian Z; Song H; Zhao Y; Zeng X
Int J Rheum Dis; 2018 May; 21(5):1068-1075. PubMed ID: 29624870
[TBL] [Abstract][Full Text] [Related]
13. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience.
Abrol E; González-Pulido C; Praena-Fernández JM; Isenberg DA
Clin Med (Lond); 2014 Apr; 14(2):157-64. PubMed ID: 24715127
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.
Bartoloni E; Baldini C; Schillaci G; Quartuccio L; Priori R; Carubbi F; Bini V; Alunno A; Bombardieri S; De Vita S; Valesini G; Giacomelli R; Gerli R
J Intern Med; 2015 Aug; 278(2):185-92. PubMed ID: 25582881
[TBL] [Abstract][Full Text] [Related]
17. Primary Sjogren's syndrome and the risk of acute pancreatitis: a nationwide cohort study.
Chang CC; Chang YS; Wang SH; Lin SY; Chen YH; Chen JH
BMJ Open; 2017 Aug; 7(8):e014807. PubMed ID: 28801391
[TBL] [Abstract][Full Text] [Related]
18. Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics.
Kvarnström M; Ottosson V; Nordmark B; Wahren-Herlenius M
Scand J Rheumatol; 2015; 44(2):135-42. PubMed ID: 25222653
[TBL] [Abstract][Full Text] [Related]
19. Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren's syndrome in Korea: A nationwide, population-based study.
Kim HJ; Kim KH; Hann HJ; Han S; Kim Y; Lee SH; Kim DS; Ahn HS
Semin Arthritis Rheum; 2017 Oct; 47(2):222-227. PubMed ID: 28729155
[TBL] [Abstract][Full Text] [Related]
20. Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren's syndrome measured using the Korean Health Insurance Claims Database.
Ahn JK; Hwang J; Seo GH
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):40-46. PubMed ID: 31969226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]